CRP and Crohn disease: Conventional measures including clinical/endoscopic activity scores (Mayo, Crohn’s Disease Activity Index) and biochemical indices (C-reactive protein, fecal calprotectin) have proved useful for monitoring patients but remain inadequate for predicting response to therapy.